Skip to main content

Table 1 Characteristics of study patients at baseline

From: Comparison of the effects of lanthanum carbonate and calcium carbonate on the progression of cardiac valvular calcification after initiation of hemodialysis

 LC (n = 24)CC (n = 26)p value
Age (year)66.9 ± 14.962.4 ± 14.40.27
Male (%)21 (88)15 (58)0.04
BMI (kg/m2)24.5 ± 3.423.5 ± 3.50.29
SBP (mmHg)146.9 ± 18.2148.2 ± 19.50.82
DBP (mmHg)70.7 ± 13.875.1 ± 15.50.30
PP (bpm)76.2 ± 19.173.0 ± 14.20.51
smoking (%)16 (67)17 (65)1.00
Diabetes (%)14 (58)8 (31)0.09
CVD (%)4 (17)5 (19)1.00
Vitamin D (%)8 (33)8 (31)1.00
Statin (%)11 (46)19 (73)0.09
ACE-I/ARB (%)13 (54)16 (62)0.81
Warfarin (%)0 (0)4 (15)0.14
Hb (g/dL)9.0 ± 1.28.7 ± 1.20.41
Alb (g/dL)3.3 ± 0.63.4 ± 0.50.89
BUN (mg/dL)88.3 ± 24.394.0 ± 27.20.44
Cr (mg/dL)8.8 ± 1.98.5 ± 1.70.62
cCa (mg/dL)8.5 ± 0.88.4 ± 0.80.73
P (mg/dL)6.0 ± 1.35.9 ± 1.50.89
CRP (mg/dL)0.46 ± 0.860.54 ± 0.740.75
LDL-C (mg/dL)86.0 ± 37.286.8 ± 30.60.94
iPTH (pg/mL)216.0 (128.5–531.8)281.0 (217.8–422.5)0.70
iFGF23 (pg/mL)737.5 (456.8–1875.9)588.1 (264.5–1880.6)0.57
EF (%)66.1 ± 6.062.1 ± 9.00.07
LVMI (g/m2)157.5 ± 45.0172.1 ± 53.60.30
IMT (mm)1.0 (0.9–1.4)0.9 (0.6–1.4)0.34
PS6.7 (3.8–14.1)5.6 (1.3–11.6)0.28
  1. Values are presented as the median and interquartile or mean ± SD
  2. LC lanthanum carbonate group, CC calcium carbonate, SBP systolic blood pressure, DBP diastolic blood pressure, PR pulse pressure, CVD cardiac vascular disease, ACE-I/ARB angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker, Hb hemoglobin, Alb albumin, Cr creatinine, BUN blood urea nitrogen, cCa corrected calcium, P phosphorus, CRP C-reactive protein, LDL-C low density lipoprotein cholesterol, iPTH intact parathyroid hormone, iFGF23 intact fibroblast growth factor 23, EF ejection fraction, LVMI left ventricular mass index, IMT intima-media thickness, PS plaque score